Published in Br J Ophthalmol on March 08, 2007
Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models. Front Immunol (2012) 0.78
Uveal melanoma as a target for immune-therapy. Ann Transl Med (2016) 0.77
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol (2002) 4.64
Dendritic cells: unique leukocyte populations which control the primary immune response. Blood (1997) 4.40
Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol (2000) 2.30
Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol (2004) 2.22
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol (2002) 1.71
Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol (1989) 1.60
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol (2004) 1.49
Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.41
Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci (1993) 1.40
TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol (2005) 1.36
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication. J Immunol (2004) 1.29
Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci (2004) 1.11
Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv Exp Med Biol (1993) 1.09
Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol (2005) 1.07
Distinct populations of dendritic cells in the normal human donor corneal epithelium. Invest Ophthalmol Vis Sci (2005) 1.05
Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes. Cancer Res (2004) 1.04
Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res (2000) 1.01
HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefes Arch Clin Exp Ophthalmol (1996) 1.01
Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines. Melanoma Res (1999) 0.98
Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int Immunol (2001) 0.95
The distribution of immune cells in the uveal tract of the normal eye. Eye (Lond) (1997) 0.91
Human NK cell IFN-gamma production is regulated by endogenous TGF-beta. Int Immunopharmacol (2006) 0.91
The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res (2001) 0.90
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol Immunother (1991) 0.90
TGF-beta in uveal melanoma. Microsc Res Tech (2001) 0.87
Morphologic and immunophenotypic heterogeneity of corneal dendritic cells. Graefes Arch Clin Exp Ophthalmol (1991) 0.86
Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163. Int J Exp Pathol (2004) 0.85
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. J Immunol (2004) 0.84
Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro. Melanoma Res (2004) 0.83
Maintenance of immune tolerance depends on normal tissue homeostasis. J Immunol (2005) 0.82
Presence and maturity of dendritic cells in melanoma lymph node metastases. J Pathol (2005) 0.81
Immunolocalization of growth factors in the human ciliary body epithelium. Curr Eye Res (1993) 0.79
Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response. Br J Ophthalmol (2005) 0.79
Apoptotic cell death in conjunction with CD80 costimulation confers uveal melanoma cells with the ability to induce immune responses. Immunology (2003) 0.77
Transforming growth factor-beta isoforms and receptors in endometriotic cysts of the human ovary. Am J Reprod Immunol (1999) 0.77
Impacts of fishing low-trophic level species on marine ecosystems. Science (2011) 2.82
S(p)O(2) values in acute medical admissions breathing air--implications for the British Thoracic Society guideline for emergency oxygen use in adult patients? Resuscitation (2012) 2.68
Should age be included as a component of track and trigger systems used to identify sick adult patients? Resuscitation (2008) 2.21
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol (2003) 2.11
Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma. Paediatr Anaesth (2013) 1.99
An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Int J Lepr Other Mycobact Dis (2004) 1.82
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol (2002) 1.67
Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res (2010) 1.59
Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol (2011) 1.53
Gastric metastases from conjunctival melanoma. Melanoma Res (2007) 1.53
The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med (2007) 1.50
Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life. J Allergy Clin Immunol (2006) 1.49
Tophaceous gout presenting as a dorsal nasal lump. J Laryngol Otol (2005) 1.39
Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci (2011) 1.37
Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res (2005) 1.37
Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol (2006) 1.36
Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol (2006) 1.33
Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci (2002) 1.33
A review, and performance evaluation, of single-parameter "track and trigger" systems. Resuscitation (2008) 1.33
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol (2006) 1.28
Guideline on the requirements of external quality assessment programs in molecular pathology. Virchows Arch (2012) 1.24
Cancer cell adaptation to chemotherapy. BMC Cancer (2005) 1.21
Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.18
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol (2010) 1.15
Calculating early warning scores--a classroom comparison of pen and paper and hand-held computer methods. Resuscitation (2006) 1.13
Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images. IEEE Trans Med Imaging (2016) 1.12
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma. BMC Cancer (2003) 1.11
Patterns of expression of DNA repair genes and relapse from melanoma. Clin Cancer Res (2010) 1.09
Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases. Histopathology (2010) 1.09
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.08
Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol (2002) 1.07
Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci (2008) 1.03
Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. Methods Mol Med (2005) 1.03
Recent advances in the diagnostic pathology of salivary carcinomas. Virchows Arch (2014) 1.02
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One (2012) 1.01
A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma. J Immunol (2007) 1.01
Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci (2009) 1.00
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer (2009) 1.00
Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J Gen Virol (2002) 0.99
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine (2007) 0.98
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer (2003) 0.98
Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J Immunol (2003) 0.96
Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci (2007) 0.95
Heat shock protein expression in the eye and in uveal melanoma. Invest Ophthalmol Vis Sci (2003) 0.95
Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med (2011) 0.95
Macrophages are vital in spontaneous intraocular tumor eradication. Invest Ophthalmol Vis Sci (2006) 0.94
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapy. J Clin Pathol (2010) 0.94
Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev (2010) 0.94
Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Anticancer Drugs (2003) 0.94
Spectrum of RB1 mutations identified in 403 retinoblastoma patients. J Med Genet (2013) 0.92
Tamoxifen-induced regression of a choroidal metastasis in a man. Arch Ophthalmol (2005) 0.92
The effect of pentamidine on melanoma ex vivo. Anticancer Drugs (2010) 0.91
Epigenetic silencing of MHC2TA transcription in cancer. Biochem Pharmacol (2006) 0.91
Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest Ophthalmol Vis Sci (2010) 0.91
The value of combining anterior segment fluorescein angiography with indocyanine green angiography in scleral inflammation. Ophthalmology (2003) 0.91
Factors associated with maternal dietary intake, feeding and weaning practices, and the development of food hypersensitivity in the infant. Pediatr Allergy Immunol (2009) 0.90
Sensory environment on health-related outcomes of hospital patients. Cochrane Database Syst Rev (2012) 0.90
Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol (2007) 0.90
Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci (2005) 0.89
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. BMC Cancer (2004) 0.88
Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes. J Immunol (2008) 0.88
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations. Histopathology (2013) 0.88
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay. Anticancer Drugs (2005) 0.88
Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall. Am J Surg Pathol (2012) 0.87
High-throughput screening of natural products for cancer therapy. Planta Med (2010) 0.87
Heterogeneity of chemosensitivity of esophageal and gastric carcinoma. Anticancer Drugs (2003) 0.87
Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci (2002) 0.87
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs (2003) 0.87
Patterns of sensitization to food and aeroallergens in the first 3 years of life. J Allergy Clin Immunol (2007) 0.87
Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines. Anticancer Drugs (2006) 0.87
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples. Mol Cancer Ther (2004) 0.87
Uveal melanoma: the inflammatory microenvironment. J Innate Immun (2012) 0.87
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.87
Prognostic value of S-100-beta serum concentration in patients with uveal melanoma. Arch Ophthalmol (2003) 0.86
Effect of bedroom size on falls in hospital: does one size fit all? J Am Geriatr Soc (2011) 0.86
Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer (2006) 0.86
Melanoma vaccines: The problems of local immunosuppression. Hum Immunol (2009) 0.86
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma. J Immunol (2012) 0.85
Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era. Clin Breast Cancer (2008) 0.85
In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva. Ophthalmology (2010) 0.85
Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest Ophthalmol Vis Sci (2006) 0.85
Continuous low-dose GM-CSF as salvage therapy in refractory recurrent breast or female genital tract carcinoma. Oncology (Williston Park) (2005) 0.85
Recurrence of treated ciliary body melanoma following trabeculectomy. Clin Experiment Ophthalmol (2009) 0.84
Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens. Invest Ophthalmol Vis Sci (2005) 0.84
Prospective study of sentinel lymph node biopsy for conjunctival melanoma. Br J Ophthalmol (2013) 0.84
A fish scale-derived collagen matrix as artificial cornea in rats: properties and potential. Invest Ophthalmol Vis Sci (2013) 0.84
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. J Immunol (2004) 0.84
Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res (2011) 0.83